Form 483

Qualgen, LLC Form 483, 2022-09-30

FDA issued a Form 483 to Qualgen, LLC on 2022-09-30 with 9 public-safe observations.

483· Form 483 issuedHuman Drugs9 observations

Qualgen, LLC · Edmond, United States · Issued September 30, 2022

Overview

  • 9 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

30 Sep 2022
21 CFR 211.110(a)

Written in-process control procedures

Cited by Patty P Kaewussdangkul, Margaret M Annes

30 Sep 2022
21 CFR 211.113(b)

Validation lacking for sterile drug products

Cited by Patty P Kaewussdangkul, Margaret M Annes

30 Sep 2022
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Patty P Kaewussdangkul, Margaret M Annes

30 Sep 2022
21 CFR 211.165(f)

Failing drug products not rejected

Cited by Patty P Kaewussdangkul, Margaret M Annes

30 Sep 2022
21 CFR 211.188

Prepared for each batch, include complete information

Cited by Patty P Kaewussdangkul, Margaret M Annes

Inspected site

QLQualgen, LLCEdmond, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(f)Cited across public-safe Form 483 observations1x
21 CFR 211.188Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.56(c)Cited across public-safe Form 483 observations1x
FDCA 503B(a)(10)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere